Sqy Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy (NCT05753462) | Sqy Therapeutics | 2023-04-26 |
Track Sqy Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.